Merck & Co., Inc. Research and Development Expense
Merck & Co., Inc. (MRK) reported Research and Development Expense of $9.74 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07
- Merck & Co., Inc. research and development expense for the quarter ending 2026-06-30 was $9.74B, a 140.64% increase year-over-year.
- Merck & Co., Inc. research and development expense for the quarter ending 2026-03-31 was $12.59B, a 247.75% increase year-over-year.
- Merck & Co., Inc. research and development expense for the quarter ending 2025-12-31 was $3.89B, a 15.23% decline year-over-year.
- Merck & Co., Inc. research and development expense for the quarter ending 2025-09-30 was $4.23B, a 27.77% decline year-over-year.
- Merck & Co., Inc. research and development expense for fiscal 2025 was $15.79B, a 11.98% decline from fiscal 2024.
- Merck & Co., Inc. research and development expense for fiscal 2024 was $17.94B, a 41.25% decline from fiscal 2023.
- Merck & Co., Inc. research and development expense for fiscal 2023 was $30.53B, a 125.35% increase from fiscal 2022.
- Merck & Co., Inc. research and development expense for fiscal 2022 was $13.55B, a 10.64% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.74B 10-Q · filed 2026-08-07 | $22.33B 10-Q · filed 2026-08-07 | $26.22B derived: sum of 3 quarters · filed 2026-08-07 | $30.45B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $12.59B 10-Q · filed 2026-05-04 | $16.48B derived: sum of 2 quarters · filed 2026-05-04 | $20.71B derived: sum of 3 quarters · filed 2026-05-04 | $24.76B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $3.89B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.12B derived: sum of 2 quarters · filed 2026-02-24 | $12.17B derived: sum of 3 quarters · filed 2026-08-07 | $15.79B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $4.23B 10-Q · filed 2025-11-05 | $8.28B derived: sum of 2 quarters · filed 2026-08-07 | $11.90B 10-Q · filed 2025-11-05 | $16.49B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $4.05B 10-Q · filed 2026-08-07 | $7.67B 10-Q · filed 2026-08-07 | $12.25B derived: sum of 3 quarters · filed 2026-08-07 | $18.11B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $3.62B 10-Q · filed 2026-05-04 | $8.21B derived: sum of 2 quarters · filed 2026-05-04 | $14.07B derived: sum of 3 quarters · filed 2026-05-04 | $17.57B derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $4.58B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $10.45B derived: sum of 2 quarters · filed 2026-02-24 | $13.95B derived: sum of 3 quarters · filed 2026-02-24 | $17.94B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $5.86B 10-Q · filed 2025-11-05 | $9.36B derived: sum of 2 quarters · filed 2025-11-05 | $13.35B 10-Q · filed 2025-11-05 | $22.98B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $3.50B 10-Q · filed 2025-08-05 | $7.49B 10-Q · filed 2025-08-05 | $17.12B derived: sum of 3 quarters · filed 2026-02-24 | $20.43B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $3.99B 10-Q · filed 2025-05-02 | $13.62B derived: sum of 2 quarters · filed 2026-02-24 | $16.93B derived: sum of 3 quarters · filed 2026-02-24 | $30.25B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $9.63B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $12.93B derived: sum of 2 quarters · filed 2026-02-24 | $26.25B derived: sum of 3 quarters · filed 2026-02-24 | $30.53B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $3.31B 10-Q · filed 2024-11-06 | $16.63B derived: sum of 2 quarters · filed 2024-11-06 | $20.90B 10-Q · filed 2024-11-06 | $24.68B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $13.32B 10-Q · filed 2024-08-05 | $17.60B 10-Q · filed 2024-08-05 | $21.37B derived: sum of 3 quarters · filed 2025-02-25 | $25.77B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $4.28B 10-Q · filed 2024-05-03 | $8.05B derived: sum of 2 quarters · filed 2025-02-25 | $12.45B derived: sum of 3 quarters · filed 2025-02-25 | $15.25B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $3.77B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $8.17B derived: sum of 2 quarters · filed 2025-02-25 | $10.97B derived: sum of 3 quarters · filed 2025-02-25 | $13.55B 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $4.40B 10-Q · filed 2023-11-03 | $7.20B derived: sum of 2 quarters · filed 2023-11-03 | $9.77B 10-Q · filed 2023-11-03 | $12.84B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $2.80B 10-Q · filed 2023-08-07 | $5.37B 10-Q · filed 2023-08-07 | $8.44B derived: sum of 3 quarters · filed 2024-02-26 | $10.89B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $2.58B 10-Q · filed 2023-05-05 | $5.64B derived: sum of 2 quarters · filed 2024-02-26 | $8.09B derived: sum of 3 quarters · filed 2024-02-26 | $12.41B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $3.07B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $5.51B derived: sum of 2 quarters · filed 2024-02-26 | $9.83B derived: sum of 3 quarters · filed 2024-02-26 | $12.24B 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $2.44B 10-Q · filed 2022-11-03 | $6.77B derived: sum of 2 quarters · filed 2022-11-03 | $9.18B 10-Q · filed 2022-11-03 | $14.97B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $4.32B 10-Q · filed 2022-08-05 | $6.73B 10-Q · filed 2022-08-05 | $12.52B derived: sum of 3 quarters · filed 2023-02-24 | $15.87B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $2.41B 10-Q · filed 2022-05-05 | $2.46B 10-Q · filed 2021-05-05 | $8.20B derived: sum of 2 quarters · filed 2023-02-24 | $11.55B derived: sum of 3 quarters · filed 2023-02-24 | $13.63B derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | $5.79B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $9.14B derived: sum of 2 quarters · filed 2023-02-24 | $11.22B derived: sum of 3 quarters · filed 2023-02-24 | $13.40B 10-K · filed 2023-02-24 | $13.56B 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $3.35B 10-Q · filed 2021-11-05 | $3.39B 10-Q · filed 2020-11-05 | $5.43B derived: sum of 2 quarters · filed 2021-11-05 | $7.61B 10-Q · filed 2021-11-05 | $7.72B 10-Q · filed 2020-11-05 | $10.04B derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-06-30 | $2.08B 10-Q · filed 2021-08-09 | $2.12B 10-Q · filed 2020-08-05 | $4.26B 10-Q · filed 2021-08-09 | $4.33B 10-Q · filed 2020-08-05 | $6.69B derived: sum of 3 quarters · filed 2022-02-25 | $9.90B derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-03-31 | $2.21B 10-Q · filed 2021-05-05 | $4.61B derived: sum of 2 quarters · filed 2022-02-25 | $7.81B derived: sum of 3 quarters · filed 2022-02-25 | $10.00B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $2.40B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $5.60B derived: sum of 2 quarters · filed 2022-02-25 | $7.79B derived: sum of 3 quarters · filed 2022-02-25 | $9.72B 10-K · filed 2022-02-25 | $9.87B 10-K · filed 2020-02-26 | |||
| 2019-09-30 | $3.20B 10-Q · filed 2020-11-05 | $5.39B derived: sum of 2 quarters · filed 2020-11-05 | $7.32B 10-Q · filed 2020-11-05 | $9.54B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $2.19B 10-Q · filed 2020-08-05 | $4.12B 10-Q · filed 2020-08-05 | $6.33B derived: sum of 3 quarters · filed 2021-02-25 | $8.40B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $1.93B 10-Q · filed 2020-05-06 | $4.14B derived: sum of 2 quarters · filed 2021-02-25 | $6.21B derived: sum of 3 quarters · filed 2021-02-25 | $8.49B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $2.21B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.28B derived: sum of 2 quarters · filed 2021-02-25 | $6.56B derived: sum of 3 quarters · filed 2021-02-25 | $9.75B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $2.07B 10-Q · filed 2019-11-05 | $4.34B derived: sum of 2 quarters · filed 2019-11-05 | $7.54B 10-Q · filed 2019-11-05 | $9.85B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $2.27B 10-Q · filed 2019-08-06 | $5.47B 10-Q · filed 2019-08-06 | $7.79B derived: sum of 3 quarters · filed 2020-02-26 | $12.20B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $3.20B 10-Q · filed 2019-05-08 | $5.51B derived: sum of 2 quarters · filed 2020-02-26 | $9.92B derived: sum of 3 quarters · filed 2020-02-26 | $11.71B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $2.31B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $6.73B derived: sum of 2 quarters · filed 2020-02-26 | $8.51B derived: sum of 3 quarters · filed 2020-02-26 | $10.34B 10-K · filed 2020-02-26 | $10.21B 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $4.41B 10-Q · filed 2018-11-06 | $4.38B 10-Q · filed 2017-11-07 | $6.20B derived: sum of 2 quarters · filed 2018-11-06 | $8.02B 10-Q · filed 2018-11-06 | $7.93B 10-Q · filed 2017-11-07 | $12.81B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | $1.78B 10-Q · filed 2018-08-07 | $1.75B 10-Q · filed 2017-08-08 | $3.61B 10-Q · filed 2018-08-07 | $3.54B 10-Q · filed 2017-08-08 | $8.40B derived: sum of 3 quarters · filed 2019-02-27 | $10.06B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | $1.83B 10-Q · filed 2018-05-08 | $1.80B 10-Q · filed 2017-05-09 | $6.62B derived: sum of 2 quarters · filed 2019-02-27 | $8.28B derived: sum of 3 quarters · filed 2019-02-27 | $10.43B derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2016-12-31 | $4.79B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $6.45B derived: sum of 2 quarters · filed 2019-02-27 | $8.60B derived: sum of 3 quarters · filed 2019-02-27 | $10.26B 10-K · filed 2019-02-27 | $10.12B 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $1.66B 10-Q · filed 2017-11-07 | $3.81B derived: sum of 2 quarters · filed 2017-11-07 | $5.47B 10-Q · filed 2017-11-07 | $7.27B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $2.15B 10-Q · filed 2017-08-08 | $3.81B 10-Q · filed 2017-08-08 | $5.61B derived: sum of 3 quarters · filed 2018-02-27 | $7.11B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $1.66B 10-Q · filed 2017-05-09 | $3.46B derived: sum of 2 quarters · filed 2018-02-27 | $4.96B derived: sum of 3 quarters · filed 2018-02-27 | $6.63B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $1.80B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.30B derived: sum of 2 quarters · filed 2018-02-27 | $4.97B derived: sum of 3 quarters · filed 2018-02-27 | $6.70B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $1.50B 10-Q · filed 2016-11-07 | $3.17B derived: sum of 2 quarters · filed 2016-11-07 | $4.91B 10-Q · filed 2016-11-07 | $7.19B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $1.67B 10-Q · filed 2016-08-08 | $3.41B 10-Q · filed 2016-08-08 | $5.69B derived: sum of 3 quarters · filed 2017-02-28 | $7.35B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $1.74B 10-Q · filed 2016-05-09 | $4.02B derived: sum of 2 quarters · filed 2017-02-28 | $5.68B derived: sum of 3 quarters · filed 2017-02-28 | $7.34B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $2.28B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $3.94B derived: sum of 2 quarters · filed 2017-02-28 | $5.61B derived: sum of 3 quarters · filed 2017-02-28 | $7.18B 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $1.66B 10-Q · filed 2015-11-05 | $3.32B derived: sum of 2 quarters · filed 2015-11-05 | $4.90B 10-Q · filed 2015-11-05 | $6.73B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $1.66B 10-Q · filed 2015-08-06 | $3.24B 10-Q · filed 2015-08-06 | $5.07B derived: sum of 3 quarters · filed 2016-02-26 | $6.73B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $1.57B 10-Q · filed 2015-05-07 | $3.41B derived: sum of 2 quarters · filed 2016-02-26 | $5.07B derived: sum of 3 quarters · filed 2016-02-26 | $7.17B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $1.83B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $3.50B derived: sum of 2 quarters · filed 2016-02-26 | $5.60B derived: sum of 3 quarters · filed 2016-02-26 | $7.50B 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $1.66B 10-Q · filed 2014-11-10 | $3.76B derived: sum of 2 quarters · filed 2014-11-10 | $5.67B 10-Q · filed 2014-11-10 | $7.89B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $2.10B 10-Q · filed 2014-08-07 | $4.01B 10-Q · filed 2014-08-07 | $6.23B derived: sum of 3 quarters · filed 2015-02-27 | $8.15B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $1.91B 10-Q · filed 2014-05-08 | $4.13B derived: sum of 2 quarters · filed 2015-02-27 | $6.05B derived: sum of 3 quarters · filed 2015-02-27 | $8.21B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $2.22B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $4.14B derived: sum of 2 quarters · filed 2015-02-27 | $6.31B derived: sum of 3 quarters · filed 2015-02-27 | $8.17B 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $1.92B 10-Q · filed 2013-11-07 | $4.08B derived: sum of 2 quarters · filed 2013-11-07 | $5.94B 10-Q · filed 2013-11-07 | $8.36B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $2.17B 10-Q · filed 2013-08-07 | $4.03B 10-Q · filed 2013-08-07 | $6.45B derived: sum of 3 quarters · filed 2014-02-27 | $8.40B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $1.86B 10-Q · filed 2013-05-09 | $4.28B derived: sum of 2 quarters · filed 2014-02-27 | $6.24B derived: sum of 3 quarters · filed 2014-02-27 | $8.17B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $2.42B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $4.37B derived: sum of 2 quarters · filed 2014-02-27 | $6.31B derived: sum of 3 quarters · filed 2014-02-27 | $8.47B 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $1.95B 10-Q · filed 2012-11-09 | $3.89B derived: sum of 2 quarters · filed 2012-11-09 | $6.05B 10-Q · filed 2012-11-09 | $10.61B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $1.94B 10-Q · filed 2012-08-07 | $4.09B 10-Q · filed 2012-08-07 | $8.65B derived: sum of 3 quarters · filed 2013-02-28 | $10.97B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $2.16B 10-Q · filed 2012-05-08 | $6.72B derived: sum of 2 quarters · filed 2013-02-28 | $9.04B derived: sum of 3 quarters · filed 2013-02-28 | $11.22B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $4.56B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $6.88B derived: sum of 2 quarters · filed 2013-02-28 | $9.06B derived: sum of 3 quarters · filed 2013-02-28 | $11.11B 10-K · filed 2013-02-28 | $10.99B 10-K · filed 2011-02-28 | |||
| 2010-09-30 | $2.32B 10-Q · filed 2011-11-08 | $2.30B 10-Q · filed 2010-11-08 | $4.50B derived: sum of 2 quarters · filed 2011-11-08 | $6.55B 10-Q · filed 2011-11-08 | $6.47B 10-Q · filed 2010-11-08 | $8.52B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-06-30 | $2.18B 10-Q · filed 2011-08-08 | $2.15B 10-Q · filed 2010-08-06 | $4.23B 10-Q · filed 2011-08-08 | $4.18B 10-Q · filed 2010-08-06 | $6.20B derived: sum of 3 quarters · filed 2012-02-28 | $7.46B derived: sum of 4 quarters · filed 2012-02-28 | ||
| 2010-03-31 | $2.05B 10-Q · filed 2011-05-09 | $2.03B 10-Q · filed 2010-05-07 | $4.02B derived: sum of 2 quarters · filed 2012-02-28 | $5.28B derived: sum of 3 quarters · filed 2012-02-28 | $6.67B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | $1.97B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $3.23B derived: sum of 2 quarters · filed 2012-02-28 | $4.62B derived: sum of 3 quarters · filed 2012-02-28 | $5.84B 10-K · filed 2012-02-28 | ||||
| 2009-09-30 | $1.25B 10-Q · filed 2010-11-08 | $913.00M 10-Q · filed 2009-10-29 | $2.65B derived: sum of 2 quarters · filed 2010-11-08 | $3.87B 10-Q · filed 2010-11-08 | $2.58B 10-Q · filed 2009-10-29 | $6.00B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-06-30 | $1.40B 10-Q · filed 2010-08-06 | $863.00M 10-Q · filed 2009-07-24 | $2.62B 10-Q · filed 2010-08-06 | $1.67B 10-Q · filed 2009-07-24 | $4.75B derived: sum of 3 quarters · filed 2011-02-28 | $5.64B derived: sum of 4 quarters · filed 2011-02-28 | ||
| 2009-03-31 | $1.22B 10-Q · filed 2010-05-07 | $3.35B derived: sum of 2 quarters · filed 2011-02-28 | $4.24B derived: sum of 3 quarters · filed 2011-02-28 | $5.15B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $2.13B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $3.02B derived: sum of 2 quarters · filed 2011-02-28 | $3.92B derived: sum of 3 quarters · filed 2011-02-28 | $4.80B 10-K · filed 2011-02-28 | $4.81B 10-K · filed 2010-03-01 | |||
| 2008-09-30 | $893.00M 10-Q · filed 2009-10-29 | $1.80B derived: sum of 2 quarters · filed 2009-10-29 | $2.68B 10-Q · filed 2009-10-29 | |||||
| 2008-06-30 | $906.00M 10-Q · filed 2009-07-24 | $1.79B 10-Q · filed 2009-07-24 | ||||||
| 2007-12-31 | $4.88B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |